Could a gut makeover ease ADHD? a trial tests FMT in teens

NCT ID NCT07756255

First seen Aug 10, 2026 · Last updated Aug 11, 2026 · Updated 1 time

Summary

This phase 2 trial explores whether fecal microbiota transplantation (FMT) is safe, tolerable, and practical for adolescents aged 13–17 with ADHD. Participants receive oral FMT capsules after bowel prep, alongside antibiotics, to see if changing gut bacteria can influence ADHD symptoms. The study focuses on feasibility, safety, and tolerability, not yet on whether it works.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Fecal microbiota transplant (FMT) capsules, given with antibiotics (nitazoxanide and vancomycin) and bowel prep
What this could lead to
If FMT proves safe and feasible, it could open a new avenue for managing ADHD symptoms by altering the gut microbiome.
What could go wrong
This is an early-phase trial focused on safety and feasibility, not proof of effectiveness. FMT carries risks like infection or gastrointestinal discomfort, and results may not generalize.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADHD are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Calgary

    Calgary, Alberta, T2M 1R5, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.